Drug intelligence / Profile preview

PROMUS Stent

Development stage
Unknown
Lead developer
Boston Scientific
Modality
Small Molecules
Administration
Intra-arterial
01

Overview

The PROMUS Stent is a drug-eluting coronary stent system developed by Boston Scientific for the treatment of coronary artery disease. It consists of a balloon-expandable stent made from a platinum chromium alloy (PtCr) coated with a biocompatible PVDF-HFP polymer that facilitates the controlled release of everolimus. Everolimus is an immunosuppressive and antiproliferative agent that inhibits the mammalian target of rapamycin (mTOR) pathway, thereby reducing smooth muscle cell proliferation and neointimal hyperplasia to prevent restenosis. The stent is indicated for improving luminal diameter in patients with symptomatic heart disease or silent ischemia caused by de novo lesions in native coronary arteries.

Brand names
PROMUSPROMUS ElementPROMUS ELITEPROMUS PREMIER
Other names
PROMUS Everolimus-Eluting Coronary Stent System
02

Targets

Mechanistic target of rapamycin kinase complex 2Mechanistic target of rapamycin complex 1

Beyond the preview

Go deeper on PROMUS Stent.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PROMUS Stent.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call